Celyad Oncology SA — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2022)

-€40.9M

Total Assets (FY2022)

€19.7M

Total Equity (FY2022)

€4.3M

Cash Flows from Operating Activities (FY2022)

-€28.0M

Source: Celyad Oncology SA 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.